Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|30|4629-4637

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.30, 2016-09, pp. : 4629-4637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Asymmetric Dimethylarginine in Cardiorenal Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2448-2455

Bentham Science Publishers

Access to resources Recommend Favorite

Signal Transduction Pathways of Inflammatory Gene Expressions and Therapeutic Implications

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3497-3508

Bentham Science Publishers

Access to resources Recommend Favorite

Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-01 ,pp. : 1867-1880

Bentham Science Publishers

Access to resources Recommend Favorite

Ethnicity and Inflammatory Pathways - Implications for Vascular Disease, Vascular Risk and Therapeutic Intervention

By  

Current Medicinal Chemistry, Vol. 14, Iss. 13, 2007-01 ,pp. : 1409-1425

Bentham Science Publishers

Access to resources Recommend Favorite

SSRIs and Intraocular Pressure Modifications: Evidence, Therapeutic Implications and Possible Mechanisms

By Costagliola C.   Parmeggiani F.   Sebastiani A.  

CNS Drugs, Vol. 18, Iss. 8, 2004-01 ,pp. : 475-484

Adis International

Access to resources Recommend Favorite